Programs

Ovarian Cancer Treatment in Israel

Ovarian cancer is the 8th most common carcinoma among women in the United States. While the precise cause of the disease are as of yet unknown, some known risk factors include family history of ovarian or breast cancer, history of fertility treatments, high number of total lifetime ovulations, age, personal history of breast carcinoma, history of endometriosis, obesity and HRT.

Before commencing ovarian cancer treatment it is important to understand what the suspicion is based on – whether it is due to elevated tumour marker levels, ascitic fluid cytology or ovarian biopsy results, ovarian biopsy, or abnormalities detected during a pelvic US scan.

Peritoneal carcinomatosis and ascites are the most common symptoms of ovarian carcinoma, appearing in over 90% of all cases. In approximately 20% of the cases peritoneal carcinomatosis is the only presentation of the disease (the tumour might not be detectable on US and MRI scans).

Diagnosis

Diagnostics phase will include:

  • Comprehensive lab workup (CBC, CMP, electrolyte levels, coagulation factors, reproductive hormones levels and tumour markers)
  • PET CT scan to assess the primary tumour and rule out distant/bone mets)
  • Biopsy revision (provided a pathological study was performed in the past)
  • Pelvic / urogenital Doppler US scan
  • Oncological gynecologist exam

Length of diagnostics phase: 4 business days. It will take place at Assuta Medical Center’s specialized facilities, equipped with cutting edge technologies.

There are 2 options for ovarian cancer treatment in the unfortunate event the diagnosis is confirmed:

  • Surgery followed by 6 cycles of chemotherapy
  • 3 cycles of neoadjuvant chemotherapy, followed by surgery and 3 additional courses of adjuvant therapy

Your treating oncological gynecologist will determine which of these options is the most appropriate in your case.

Surgical Treatment

The surgery that is performed in cases of ovarian carcinoma with carcinomatosis is a radical hysterectomy with bilateral salpingo-oophorectomy (TAH + BSO) and omentectomy.

Cost of the operation includes:

  • Routine preoperative preparation (ECG, chest X-ray and an anesthesiologist consultation)
  • Operative procedure and up to 4 days of hospitalization at Assuta’s Department of Gynecology
  • Disposable surgical materials
  • Express pathological study and conclusive histopathological study

Please Note

The suggested treatment (by a specialist recommended by us) will take place at Assuta Medical Center, which is the best hospital in Israel. If you would like, we can instead arrange treatment for you at one of Israel’s public hospitals. In such case, the cost of the surgery (not including the logistics package) will be lower by 20 to 30 per cent. However, while we can guarantee that the surgery will be performed by one of that hospital’s top experts, the decision regarding which physician will depend on the hospitals’ schedule.